Your browser doesn't support javascript.
loading
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
Huizinga, Thomas; Choy, Ernest; Praestgaard, Amy; van Hoogstraten, Hubert; LaFontaine, Patrick R; Guyot, Patricia; Aletaha, Daniel; Müller-Ladner, Ulf; Tanaka, Yoshiya; Curtis, Jeffrey R; Fleischmann, Roy.
Afiliação
  • Huizinga T; Leiden University Medical Centre, Leiden, The Netherlands. t.w.j.huizinga@lumc.nl.
  • Choy E; CREATE Centre, Cardiff University, Cardiff, UK.
  • Praestgaard A; Sanofi, Cambridge, MA, USA.
  • van Hoogstraten H; Sanofi, Bridgewater, NJ, USA.
  • LaFontaine PR; Sanofi, Cambridge, MA, USA.
  • Guyot P; Sanofi, Chilly-Mazarin, France.
  • Aletaha D; Medical University Vienna, Vienna, Austria.
  • Müller-Ladner U; Department of Rheumatology and Clinical Immunology, Justus-Liebig University, Campus Kerckhoff, Bad Nauheim, Germany.
  • Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Curtis JR; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Fleischmann R; Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rheumatol Ther ; 10(3): 539-550, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36725768

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article